MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.
- Menarini 2022: Together we have written a story
- Menarini Pills of Art: Flora by Tiziano (english version)
- Menarini - The difference between active ingredient and drug
- XXV Fair Play Menarini Award - Sinisa Mihajlovic, Patrick Kluivert, Stephan Edberg (english)
MENARINI EMPLOYEES make all the difference, every day.
We are looking for talented people: in order to achieve our mission we need energetic, versatile people with initiative and team-work skills.
Every day we do our jobs with a great sense of commitment, knowing that we are adding more value to the creation of quality drugs.
Menarini Pills of Art
Today, with ‘Pills of Art’, Menarini enters the city’s museums to reveal some of the curious facts on the works of the most well-known Renaissance painters. An initiative which confirms the company’s affiliation with art, a close connection which has led them to publish, each year and for more than six decades, an art monograph
International Fair Play Menarini Award
International Fair Play Menarini Award: the annual event which celebrates those sporting champions who have stood out in the world of sports for the brilliant results attained whilst fully respecting the rules
Menarini and Farmindustria: together we won’t rest
COVID -19 has brought many changes to our habits and our daily lives, but together we can face - and overcome - our fears. Menarini and Farmindustria, like all of us, won't rest.
EFPIA - We won’t rest campaign
MENARINI SUPPORTS THE EFPIA CAMPAIGN - WE WON'T REST: Disease never takes a break, so neither do we. We won't rest until people around the world see a brighter tomorrow.
Subscribe to the newsletter
Subscribe to the newsletter to be updated on Menarini news.
Media Contact
To access the service it is necessary to declare to have read the privacy information.
